Wockhardt’s core business is innovation. It uses science and technology to develop medicines and other products that improve the quality of millions of people’s lives through better health.
Research is a primary focus at Wockhardt, with numerous initiatives targeting both identified market opportunities and the challenge of unmet medical needs. Addressing these goals, Wockhardt has a dedicated and infrastructurally sophisticated research complex and its investment in research is amongst the highest in the Indian pharmaceutical industry.
Multi-disciplinary R&D programmes
- Recombinant biopharmaceuticals
- Generics & Novel Drug Delivery System (NDDS)
- New Chemical Entity